These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 3261828)

  • 1. Anorectic activities of serotonin uptake inhibitors: correlation with their potencies at inhibiting serotonin uptake in vivo and 3H-mazindol binding in vitro.
    Angel I; Taranger MA; Claustre Y; Scatton B; Langer SZ
    Life Sci; 1988; 43(8):651-8. PubMed ID: 3261828
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Demonstration of specific binding sites for [3H]mazindol in rat hypothalamus: correlation with the anorectic properties of phenylethylamines.
    Angel I; Paul SM
    Eur J Pharmacol; 1985 Jul; 113(1):133-4. PubMed ID: 4043206
    [No Abstract]   [Full Text] [Related]  

  • 3. Characterization of [3H]mazindol binding in rat brain: sodium-sensitive binding correlates with the anorectic potencies of phenylethylamines.
    Angel I; Luu MD; Paul SM
    J Neurochem; 1987 Feb; 48(2):491-7. PubMed ID: 3467029
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies on the capacity of mazindol and dita to act as uptake inhibitors or releasing agents for 3H-biogenic amines in rat brain tissue slices.
    Heikkila RE; Cabbat FS; Mytilineou C
    Eur J Pharmacol; 1977 Oct; 45(4):329-33. PubMed ID: 923643
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Two novel agents affecting eating through an action on monoaminergic systems.
    Roncucci R; Miranda GF; Verry M
    Int J Obes; 1984; 8 Suppl 1():103-17. PubMed ID: 6549508
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differences in the temperature dependence of drug interaction with the noradrenaline and serotonin transporters.
    De Oliveira AM; Schoemaker H; Segonzac A; Langer SZ
    Neuropharmacology; 1989 Aug; 28(8):823-8. PubMed ID: 2528702
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological studies with several analogs of mazindol: correlation between effects on dopamine uptake and various in vivo responses.
    Heikkila RE; Babington RG; Houlihan WJ
    Eur J Pharmacol; 1981 May; 71(2-3):277-86. PubMed ID: 7250190
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anorectic activity of fluoxetine and norfluoxetine in rats: relationship between brain concentrations and in-vitro potencies on monoaminergic mechanisms.
    Caccia S; Bizzi A; Coltro G; Fracasso C; Frittoli E; Mennini T; Garattini S
    J Pharm Pharmacol; 1992 Mar; 44(3):250-4. PubMed ID: 1354734
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [3H]mazindol binding associated with neuronal dopamine and norepinephrine uptake sites.
    Javitch JA; Blaustein RO; Snyder SH
    Mol Pharmacol; 1984 Jul; 26(1):35-44. PubMed ID: 6087116
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Location and effect of obesity on putative anorectic binding sites in the rat brain.
    Dunn-Meynell AA; Levin BE
    Obes Res; 1997 May; 5(3):201-7. PubMed ID: 9192394
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of brain monoamines in the anorectic activity of mazindol and d-amphetamine in the rat.
    Samanin R; Bendotti C; Bernasconi S; Borroni E; Garattini S
    Eur J Pharmacol; 1977 May; 43(2):117-24. PubMed ID: 872869
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fluoxetine at anorectic doses does not have properties of a dopamine uptake inhibitor.
    Fuller RW; Hemrick-Luecke SK; Snoddy HD
    J Neural Transm Gen Sect; 1994; 96(3):165-77. PubMed ID: 7826568
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypothalamic microdialysis of mazindol causes anorexia with increase in synaptic serotonin in rats.
    Shimizu N; Take S; Hori T; Oomura Y
    Physiol Behav; 1991 Jan; 49(1):131-4. PubMed ID: 2017466
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of the anorectic drug recognition site during glucoprivic feeding.
    Angel I; Hauger RL; Giblin BA; Paul SM
    Brain Res Bull; 1992 Feb; 28(2):201-7. PubMed ID: 1317740
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progress report on the anorectic effects of dexfenfluramine, fluoxetine and sertraline.
    Garattini S; Bizzi A; Caccia S; Mennini T
    Int J Obes Relat Metab Disord; 1992 Dec; 16 Suppl 3():S43-50. PubMed ID: 1338321
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of single and repeated anorectic doses of 5-hydroxytryptamine uptake inhibitors on indole levels in rat brain.
    Caccia S; Anelli M; Codegoni AM; Fracasso C; Garattini S
    Br J Pharmacol; 1993 Sep; 110(1):355-9. PubMed ID: 7693282
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unexpected differences between mazindol and its homologs on biochemical and behavioral responses.
    Heikkila RE; Cabbat FS; Manzino L; Babington RG; Houlihan WJ
    J Pharmacol Exp Ther; 1981 Jun; 217(3):745-9. PubMed ID: 7194909
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suppression of food intake in rats by fluoxetine: comparison of enantiomers and effects of serotonin antagonists.
    Wong DT; Reid LR; Threlkeld PG
    Pharmacol Biochem Behav; 1988 Oct; 31(2):475-9. PubMed ID: 3266670
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coupling between hypothalamic alpha 2-adrenoceptors and [3H]mazindol binding site in response to several hyperglycaemic stimuli in mice.
    Angel I; Taranger MA
    Brain Res; 1989 Jun; 490(2):367-72. PubMed ID: 2548657
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Site of action of anorectic drugs: glucoprivic- versus food deprivation-induced feeding.
    Angel I; Stivers JA; Paul SM; Crawley JN
    Pharmacol Biochem Behav; 1987 Jun; 27(2):291-7. PubMed ID: 3628443
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.